Miglietta, Daniela <br/><br/>
Naproxcinod shows significant advantages over naproxen in the mdx model of Duchenne Muscular Dystrophy.  [electronic resource] 

 -  Orphanet journal of rare diseases  Aug 2015 
 - 101 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1750-1172 
<br/><br/><label>Standard No.: </label>10.1186/s13023-015-0311-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Biological Availability<br/>Disease Models, Animal<br/>Male<br/>Mice<br/>Mice, Inbred C57BL<br/>Mice, Inbred mdx<br/>Muscular Dystrophy, Duchenne--drug therapy<br/>Naproxen--analogs & derivatives<br/>Nitric Oxide Donors--pharmacokinetics